BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23800341)

  • 1. Metabolite analysis distinguishes between mice with epidermolysis bullosa acquisita and healthy mice.
    Schönig S; Recke A; Hirose M; Ludwig RJ; Seeger K
    Orphanet J Rare Dis; 2013 Jun; 8():93. PubMed ID: 23800341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients.
    Woodley DT; Ram R; Doostan A; Bandyopadhyay P; Huang Y; Remington J; Hou Y; Keene DR; Liu Z; Chen M
    J Invest Dermatol; 2006 Jun; 126(6):1323-30. PubMed ID: 16543893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and diagnosis of epidermolysis bullosa acquisita.
    Vorobyev A; Ludwig RJ; Schmidt E
    Expert Rev Clin Immunol; 2017 Feb; 13(2):157-169. PubMed ID: 27580464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice.
    Hammers CM; Bieber K; Kalies K; Banczyk D; Ellebrecht CT; Ibrahim SM; Zillikens D; Ludwig RJ; Westermann J
    J Immunol; 2011 Nov; 187(10):5043-50. PubMed ID: 21967893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.
    Remington J; Chen M; Burnett J; Woodley DT
    Curr Dir Autoimmun; 2008; 10():195-205. PubMed ID: 18460887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermolysis bullosa acquisita: what's new?
    Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita.
    Woodley DT; Chang C; Saadat P; Ram R; Liu Z; Chen M
    J Invest Dermatol; 2005 May; 124(5):958-64. PubMed ID: 15854036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita.
    Ludwig RJ; Müller S; Marques Ad; Recke A; Schmidt E; Zillikens D; Möller S; Ibrahim SM
    J Invest Dermatol; 2012 May; 132(5):1409-15. PubMed ID: 22297639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermolysis bullosa acquisita.
    Gupta R; Woodley DT; Chen M
    Clin Dermatol; 2012; 30(1):60-9. PubMed ID: 22137228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomapping of EBA sera to multiple epitopes on collagen VII: further evidence that anchoring fibrils originate and terminate in the lamina densa.
    McMillan JR; Matsumura T; Hashimoto T; Schumann H; Bruckner-Tuderman L; Shimizu H
    Exp Dermatol; 2003 Jun; 12(3):261-7. PubMed ID: 12823439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.
    Woodley DT; Remington J; Chen M
    Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):78-84. PubMed ID: 18058258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of anti-type VII collagen IgE antibodies in epidermolysis bullosa acquisita.
    Koga H; Teye K; Yamashita K; Ishii N; Tsuruta D; Nakama T
    Br J Dermatol; 2019 May; 180(5):1107-1113. PubMed ID: 30311191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermolysis bullosa acquisita.
    Kim JH; Kim SC
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1204-13. PubMed ID: 23368767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita.
    Ito Y; Kasai H; Yoshida T; Saleh MA; Amagai M; Yamagami J
    J Dermatol; 2013 Nov; 40(11):864-8. PubMed ID: 24127822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita.
    Kovacs B; Tillmann J; Freund LC; Nimmerjahn F; Sadik CD; Bieber K; Ludwig RJ; Karsten CM; Köhl J
    Front Immunol; 2019; 10():3012. PubMed ID: 31993051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial epidermolysis bullosa acquisita.
    Noe MH; Chen M; Woodley DT; Fairley JA
    Dermatol Online J; 2008 Dec; 14(12):2. PubMed ID: 19265615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen.
    Chen M; Kim GH; Prakash L; Woodley DT
    Autoimmunity; 2012 Feb; 45(1):91-101. PubMed ID: 21955050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study.
    Marzano AV; Cozzani E; Fanoni D; De Pità O; Vassallo C; Berti E; Parodi A; Crosti C; Cugno M
    Br J Dermatol; 2013 Jan; 168(1):80-4. PubMed ID: 22913489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters.
    Vorobyev A; Ujiie H; Recke A; Buijsrogge JJA; Jonkman MF; Pas HH; Iwata H; Hashimoto T; Kim SC; Hoon Kim J; Groves R; Samavedam U; Gupta Y; Schmidt E; Zillikens D; Shimizu H; Ludwig RJ
    J Invest Dermatol; 2015 Jun; 135(6):1565-1573. PubMed ID: 25689103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.